z-logo
open-access-imgOpen Access
Decreased complication profile and improved clinical outcomes of primary reverse total shoulder arthroplasty after 2010: A systematic review
Author(s) -
Raphael J. Crum,
Darren de,
Favian Su,
Bryson P. Lesniak,
Albert Lin
Publication year - 2019
Publication title -
shoulder and elbow
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.506
H-Index - 15
eISSN - 1758-5740
pISSN - 1758-5732
DOI - 10.1177/1758573219852977
Subject(s) - medicine , complication , perioperative , arthroplasty , elbow , surgery , implant , physical therapy
The purpose of this review was to update the complication profile of reverse total shoulder arthroplasty (rTSA) post-2010, given greater procedural familiarity, improved learning curves, enhanced implant designs, and increased attention to the nuances of patient selection. Three electronic databases were searched and screened in duplicate from 1 January 2010 to 16 December 2018 based on predetermined criteria. Twenty-two studies examining 1455 patients (26% male; mean age: 73.4 ± 3.6; mean follow-up: 23.4 ± 14.3 months) were reviewed. Post-operative motion ranged a mean 122.4° ± 11.5° flexion, 109° ± 19.4° abduction, and 33° ± 11.2°/41° ± 5° external/internal rotation. Post-operative mean Constant score was 58.9 ± 10.1, American Shoulder Elbow Surgeon score was 73.4 ± 6.1, Simple Shoulder Test score was 63.5 ± 6.5, and a Visual Analog Scale pain score was 1.6 ± 0.9. The overall complication rate was 18.2% and major complication rate was 15.4%. Compared to pre-2010, the overall complication rate of 18.2% is lower than previous rates of 19%-68%, with the rate of "major" complications dropping three-fold from 15.4% to 4.6%. The data suggest that rTSA is a safe and efficacious alternative to aTSA and HA, and the "stale" nature of previous complication profiles are points fundamental to perioperative discussions surrounding rTSA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here